Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
Destany K. Kwon, Mohit Kwatra, Jing Wang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3736-3736
Open Access | Times Cited: 78
The Rauvolfia tetraphylla genome suggests multiple distinct biosynthetic routes for yohimbane monoterpene indole alkaloids
Emily Amor Stander, Beata Joanna Lehka, Inês Carqueijeiro, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 24
Parkinson's disease exacerbation following Levetiracetam administration: an unusual phenomenon
Laila Alqahtani, Ali Alkhaibary, Farid Bouhouf
Oxford Medical Case Reports (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 1
Protective Effects of Polysaccharides in Neurodegenerative Diseases
Yinying Wang, Rongsha Chen, Zhongshan Yang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 24
Ethnopharmacological Effects of Urtica dioica, Matricaria chamomilla, and Murraya koenigii on Rotenone-Exposed D. melanogaster: An Attenuation of Cellular, Biochemical, and Organismal Markers
Shabnam Shabir, Sumaira Yousuf, Sandeep Kumar Singh, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1623-1623
Open Access | Times Cited: 23
The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies
Mohammad Yasin Zamanian, Zahra Kamran, Marziye Ranjbar Tavakoli, et al.
Molecular Neurobiology (2025)
Closed Access
Mushroom Polysaccharides as Potential Candidates for Alleviating Neurodegenerative Diseases
Xue Jiang, Siqi Li, Xiangru Feng, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4833-4833
Open Access | Times Cited: 15
Eltoprazine modulated gamma oscillations on ameliorating L‐dopa‐induced dyskinesia in rats
Yue-Wei Bi, Pengfei Wang, Jianshen Yu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 10, pp. 2998-3013
Open Access | Times Cited: 9
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research
Mohammad Ahmed Khan, Nafis Haider, Tanveer Singh, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 3, pp. 873-919
Closed Access | Times Cited: 8
Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation
Fanshi Zhang, Mei Liu, Jinmei Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
The Pharmacological Activity of Garlic (Allium sativum) in Parkinson’s Disease: From Molecular Mechanisms to the Therapeutic Potential
Debarati Rakshit, Sudipta Nayak, Snehashis Kundu, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 6, pp. 1033-1044
Closed Access | Times Cited: 7
Parkinsonism-Hyperpyrexia Syndrome in a patient undergoing upper gastrointestinal surgery: A case report
Nissar Shaikh, A. Saadeddin
Qatar medical journal (2024) Vol. 2023, Iss. 4
Open Access | Times Cited: 2
AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia
Ke Liu, Zhaoyuan Zhang, Yu Xu, et al.
Cellular Signalling (2024) Vol. 118, pp. 111125-111125
Open Access | Times Cited: 2
miR‐221 and Parkinson's disease: A biomarker with therapeutic potential
Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, Reena Gupta, et al.
European Journal of Neuroscience (2023) Vol. 59, Iss. 2, pp. 283-297
Open Access | Times Cited: 6
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
Silvia Rota, Daniele Urso, Daniel J. van Wamelen, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Two Faces of Catechol-O-Methyltransferase Inhibitor on One-Carbon Metabolism in Parkinson’s Disease: A Meta-Analysis
Jin Hee Kim, Shaoyue Jin, Hyeyoon Eo, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 901-901
Open Access | Times Cited: 5
Anti-parkinsonian activity of the adenosine A2A receptor antagonist/inverse agonist KW-6356 as monotherapy in MPTP-treated common marmosets
Yutaro Ohno, Eri Okita, Mika Kawai-Uchida, et al.
European Journal of Pharmacology (2023) Vol. 950, pp. 175773-175773
Open Access | Times Cited: 5
Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson’s Disease in the First 6 Years of Levodopa Treatment
Yang Luo, Huiqin Chen, Mingzhen Gui
Diagnostics (2023) Vol. 13, Iss. 15, pp. 2511-2511
Open Access | Times Cited: 4
Neuroinflammation and Dyskinesia: A Possible Causative Relationship?
Antonella Cardinale, Antonio de Iure, Barbara Picconi
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 514-514
Open Access | Times Cited: 1
Unveiling differential gene co-expression networks and its effects on levodopa-induced dyskinesia
Tatiane Piedade de Souza, Gilderlânio Santana de Araújo, Leandro Magalhães, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110835-110835
Open Access | Times Cited: 1
Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
Ana Gabrielle Bispo, Caio Santos Silva, Camille Sena-dos-Santos, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2230-2230
Open Access | Times Cited: 3
Development and Evaluation of Novel Apomorphine and Quetiapine Combinational Formulation for Parkinson’s Disease in Rat: New Era (Possibilities) for Pre – Clinical Protocol Concept Review
Minesh Patel
(2023)
Open Access | Times Cited: 1
ADMINISTRATION OF LEVODOPA IN A PARKINSON’S PATIENT USING A NOVEL ORAL AND MAXILLOFACIAL ROUTE – A FIRST IN HUMAN STUDY
Suresh Thirunavukarasu, Balasubramanian Bala Venkata Ramanan, Sathya Krishnan Suresh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
M4-mediated cholinergic transmission is reduced in parkinsonian mice and its restoration alleviates motor deficits and levodopa-induced dyskinesia
Beatriz E Nielsen, Christopher Ford
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson’s Disease Pathogenesis
Xuanxiang Jin, Xiaoli Si, Xiaoguang Lei, et al.
Aging and Disease (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top